Tat'yana S Kruglova (T S Kruglova)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Community Acquired Pneumonia

Top Venues

Terapevticheskii arkhiv

Pathogens & immunity

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Roppelt, M S Lebedkina, Anton A Chernov, Tat'yana S Kruglova, Olgo A Mukhina, Yu D Yukhnovskaya, F A Samedova, U A Mаrkina, G V Andrenova, Alexander V Karaulov, Mar'yana A Lysenko, Darya S Fomina
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Terapevticheskii arkhiv 95 (1) (2023)
Anna Roppelt, M S Lebedkina, Anton A Chernov, Tat'yana S Kruglova, Olgo A Mukhina, Yu D Yukhnovskaya, F A Samedova, U A Mаrkina, G V Andrenova, Alexander V Karaulov, Mar'yana A Lysenko, Darya S Fomina
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Terapevticheskii arkhiv 95 (1) (2023)
Anna Roppelt, M S Lebedkina, Anton A Chernov, Tat'yana S Kruglova, Olgo A Mukhina, Yu D Yukhnovskaya, F A Samedova, U A Mаrkina, G V Andrenova, Alexander V Karaulov, Mar'yana A Lysenko, Darya S Fomina
[Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Terapevticheskii arkhiv 95 (1) (2023)
Tat'yana S Kruglova, Darya S Fomina
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting. Terapevticheskii arkhiv 94 (11) (2022)
A I Khripun, A V Starshinin, Y O Antipova, Mar'yana A Lysenko, Y V Urozhaeva, O F Gavrilenko, N A Rusantsova, Andrej A Tyazhelnikov, E Y Tikhonovskaya, N V Okolot, M V Sokolova, Darya S Fomina, E N Simonova, Tat'yana S Kruglova, Anton A Chernov, A I Zagrebneva
[Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients' treatment]. Terapevticheskii arkhiv 94 (5) (2022)
U A Mаrkina, Darya S Fomina, M S Lebedkina, Tat'yana S Kruglova, Anton A Chernov, A I Zagrebneva, Zinaida Yu Mutovina, Alexander V Karaulov, Ekaterina Alexeeva, Mar'yana A Lysenko
[Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit]. Terapevticheskii arkhiv 94 (5) (2022)
Tat'yana S Kruglova, Darya S Fomina
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting. Terapevticheskii arkhiv 94 (11) (2022)
Tat'yana S Kruglova, Darya S Fomina
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting. Terapevticheskii arkhiv 94 (11) (2022)
Tat'yana S Kruglova, Darya S Fomina, Nataliya G Poteshkina, N F Frolova, Irina P Beloglazova, Zinaida Yu Mutovina, Inna V Samsonova, E A Kovalevskaja, A I Zagrebneva, S A Serdotetckova, Anton A Chernov, Mar'yana A Lysenko
[Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19]. Terapevticheskii arkhiv 93 (11) (2021)
Darya S Fomina, Mar'yana A Lysenko, Irina P Beloglazova, Zinaida Yu Mutovina, Nataliya G Poteshkina, Inna V Samsonova, Tat'yana S Kruglova, Anton A Chernov, Alexander V Karaulov
Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia. Pathogens & immunity 5 (1) (2020)